Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

QBSAfe: A Novel Approach to Diabetes Management Focused on Quality of Life, Burden of Treatment, Social Integration and Avoidance of Future Events

NCT04514523 is registered in ClinicalTrials.gov with Yale University as lead sponsor.

NCT NCT04514523
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04514523 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
QBSAfe: A Novel Approach to Diabetes Management Focused on Quality of Life, Burden of Treatment, Social Integration and Avoidance of Future Events
Lead sponsor
Yale University
Phase
Not applicable
Overall status
Completed
Start date
April 28, 2020
Completion date
September 22, 2020
Enrollment
91 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes, diabetes mellitus